A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
27 Sep 2026 · 06:11 CST Terminal Access 终端入口 →
600276.SH上海证券交易所 · 主板 Main

Hengrui Pharma 恒瑞医药

Chemical Pharmaceuticals 化学制药
¥44.86−¥0.72 · −1.58%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥45.38
High 最高
¥45.77
Low 最低
¥44.60
Prev Close 昨收
¥45.58
Volume 成交量
4,235.8万股
Turnover 成交额
¥19亿
Mkt Cap 总市值
¥2,977亿
P/E 市盈率
38.5×
Recent Activity 近期动态All Filings 全部公告 →

15 significant filings since 30 May 2026: 10 on buyback and 5 on equity incentive. The latest, on 18 Sep 2026: 恒瑞医药关于首次回购公司A股股份的公告.
自 30 May 2026 起有 15 份重大公告:buyback 10 份、equity incentive 5 份。最新一份(18 Sep 2026):恒瑞医药关于首次回购公司A股股份的公告。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥71.98 · Low 最低 ¥42.67
45.0050.0055.0060.0065.0070.00
Volume 成交量
2.47亿
Sep 25Dec 25Mar 26Jun 26Sep 26

Against Its Own History 与自身历史比较

38.5×
Median 中值 60.3× · Range 区间 44.5× to 74.8× · 20 periods 期
4.62×
Median 中值 6.62× · Range 区间 5.36× to 9.39× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥52.04¥1.1744.5×¥9.715.36×
31 Mar 2026 一季报¥55.22¥1.2344.9×¥9.595.76×
31 Dec 2025 年报¥59.57¥1.1950.1×¥9.236.45×
30 Sep 2025 三季报¥71.55¥1.1661.7×¥8.977.98×
30 Jun 2025 中报¥51.90¥1.1644.7×¥8.815.89×
31 Mar 2025 一季报¥49.20¥1.0945.1×¥7.376.68×
31 Dec 2024 年报¥45.90¥1.0045.9×¥7.146.43×
30 Sep 2024 三季报¥52.30¥0.8660.8×¥6.867.62×
30 Jun 2024 中报¥38.46¥0.8644.7×¥6.685.76×
31 Mar 2024 一季报¥45.97¥0.7065.7×¥6.567.00×
31 Dec 2023 年报¥45.23¥0.6866.5×¥6.347.13×
30 Sep 2023 三季报¥44.94¥0.6668.1×¥6.217.23×
30 Jun 2023 中报¥47.90¥0.6474.8×¥6.097.86×
31 Mar 2023 一季报¥42.82¥0.6170.2×¥6.107.02×
31 Dec 2022 年报¥38.53¥0.6163.2×¥5.936.50×
30 Sep 2022 三季报¥35.10¥0.5563.8×¥5.766.09×
30 Jun 2022 中报¥37.09¥0.6259.8×¥5.656.56×
31 Mar 2022 一季报¥36.82¥0.6755.0×¥5.686.48×
31 Dec 2021 年报¥50.71¥0.7171.4×¥5.479.27×
30 Sep 2021 三季报¥50.23¥0.9851.3×¥5.359.39×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥1.37¥1.28 to ¥1.65432.7×
2027¥1.63¥1.47 to ¥1.81427.5×
2028¥1.92¥1.73 to ¥2.00423.4×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA